Upgrade to SI Premium - Free Trial

Cardlytics (CDLX) PT Lowered to $2.50 at BofA Securities

March 13, 2025 6:50 AM
BofA Securities analyst Omar Dessouky lowered the price target on Cardlytics (NASDAQ: CDLX) to $2.50 (from $4.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles